Shanghai, China

Haizhong Tan

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Haizhong Tan: A Trailblazing Inventor in the Pharmaceutical Industry**

Introduction

Haizhong Tan, an innovative inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, his work centers around developing novel compounds and methods for treating critical diseases. His inventions reflect a strong commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest patents, Haizhong Tan has developed an IRAK4 inhibitor crystal and its preparation method. This invention includes a crystal of a specific compound and its salt, alongside applications for drug preparation targeting IRAK4-related diseases. Additionally, he has created a fused ring compound that serves as a dual inhibitor for FGFR and VEGFR, showcasing his innovative approach to combat complex health issues.

Career Highlights

Haizhong has had a fruitful career, contributing his expertise to esteemed organizations, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Phaeno Therapeutics Co., Ltd. His roles in these companies have allowed him to focus on research and development, paving the way for groundbreaking pharmaceutical advancements.

Collaborations

Throughout his career, Haizhong Tan has collaborated with talented coworkers, notably Jian Li and Shuhui Chen. These partnerships have fostered a creative environment conducive to innovation, resulting in the successful development of his patented technologies.

Conclusion

In conclusion, Haizhong Tan stands out as a prominent inventor, leveraging his skills to create impactful solutions in the pharmaceutical industry. His latest patents reflect a dedication to addressing critical health challenges, and his collaborative spirit continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…